Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
heavily undervalued .. shorts will get smoked
Cresco Labs to Hold Second Quarter 2022 Earnings Conference Call on August 17, 2022
STOCKS Aug 2, 2022 • 6:30 AM EDT
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or “the Company”), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, today announced that it will report financial results for the second quarter ended June 30th, 2022, on Wednesday, August 17th, 2022, before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights.
Event: Cresco Labs Second Quarter 2022 Earnings Conference Call
Date: Wednesday, August 17th, 2022
Time: 8:30am EST
Webcast: Link
Dial-in: 1-844-200-6205 (US Toll Free), 1-833-950-0062 (Canada Toll Free), 1-646-904-5544 (US Local), +1 929-526-1599 (Other)
Access Code: 035060
Archived access to the webcast will be available for one year on the Cresco Labs investor relations website.
About Cresco Labs Inc.
Cresco Labs is one of the largest vertically integrated multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods (“CPG”) approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted national brands including Cresco, High Supply, Mindy’s Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, Cresco Labs’ national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry’s largest Social Equity and Educational Development initiative, SEED, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220801005267/en/
Media:
Jason Erkes, Cresco Labs
Chief Communications Officer
press@crescolabs.com
Investors:
investors@crescolabs.com
For general Cresco Labs inquiries:
312-929-0993
info@crescolabs.com
Source: Cresco Labs Inc.
Passing with a vote of 220-204, the MORE Act does not have overwhelming bipartisan support, with only 3 Republican representatives backing the bill.
Company reports 20% year-over-year revenue growth and 45% year-over-year adjusted EBITDA(1) growth -- and continues industry leadership in branded wholesale and retail productivity :)
Here you go boyz!
“First Quarter 2022 Financial Highlights
First quarter revenue of $214 million, up 20% year-over-year
Gross profit excluding fair value mark-up for acquired inventory of $113 million, or 53% of revenue, an increase of 29% year-over-year
First quarter adjusted EBITDA1 of $51 million, or 24% of revenue, an increase of 45% year-over-year
Wholesale revenue of $95 million, maintained position as #1 seller of branded cannabis products in U.S. with leading share in the flower, concentrates, and vape categories
Retail revenue increased 44% year-over-year, to $119 million, or $2.5 million per average store open in the quarter and same-store-sales increased 9% year-over-year
Ended the quarter with $179 million of cash on hand
Opened four new retail stores, three in Florida and one in Pennsylvania, bringing the Company’s total retail footprint to 50
Launched branded product portfolio in Florida, including High Supply®, Good News®, Remedi™ and Sunnyside* Chews”
Federal legalization buries cresco in a deep dark grave, sorry for my friends here who didn’t offload at $12-$14
Never bad to trade around a core if you can see the patterns. I find I am safer to just hold on most of my stuff. More successful for me that way
So, anyone else looking to take a little profit from the 4/20 run-up?
CRESCO's PPS suffers as Dems stumble--->>>POLITICS - Schumer’s Marijuana Legalization Bill Not Coming This Month, As Senators Work To Finalize Provisions
Published 15 hours ago on April 14, 2022
https://www.marijuanamoment.net/schumers-marijuana-legalization-bill-not-coming-this-month-as-senators-work-to-finalize-provisions/
The long-anticipated Senate bill to federally legalize marijuana will not be introduced this month, with Democratic leadership saying on Thursday that the timeline is being extended as they continue to work out various provisions “with the assistance of nearly a dozen Senate committees and input from numerous federal agencies.”
Senate Majority Leader Chuck Schumer (D-NY) has said on several occasions that the bill he’s been working on with Senate Finance Committee Chairman Ron Wyden (D-OR) and Sen. Cory Booker (D-NJ) for many months would be formally filed by the end of April. That’s no longer the case, with the leader now saying the “official introduction” will take place sometime “before the August recess.”
A discussion draft of the Cannabis Administration & Opportunity Act (CAOA) was first unveiled last year, and advocates and stakeholders have been hanging on the leader’s words as they continue to push for an end to federal prohibition. Most recently, Schumer said last week that he and colleagues were in the process of reaching out to Republican senators to “see what they want” included in the legislation.
The timeline that Schumer previewed has apparently proved too ambitious—but the hope is that by taking extra time to finalize the measure, it will help the senators overcome what are currently significant odds stacked against them to reach a high vote threshold in the chamber, where Democrats hold just a slim majority and several members of the party have indicated that they’re not supportive of legalization.
CAOA is is “critical legislation that will finally put an end to the federal prohibition on cannabis and address the over-criminalization of cannabis in a comprehensive and meaningful way,” Schumer said in a press release. “I am proud of the progress made in bringing this vital bill closer to its official introduction before the August recess, and I want to thank the committee chairs who have worked with us and remained committed to addressing this issue.”
“CAOA will not only remove cannabis from the federal list of controlled substances, but also help repair our criminal justice system, ensure restorative justice, protect public health, and implement responsible taxes and regulations,” he said.
In the process of finalizing key provisions, working to build consensus with committee leadership and GOP members, the Senate sponsors detailed “key policies” of the bill that are being taken into consideration, including some that advocates would support that weren’t included in the discussion draft such as removing or scaling back drug testing for cannabis for certain federal workers.
Here’s a list of those policy areas that are being looked at as the senators continue to work the bill:
• Removing unnecessary federal employee pre-employment and random drug testing for cannabis, while preserving appropriate drug testing in transportation-related fields, other sensitive areas of employment, and investigations of accidents and unsafe practices.
• Specifying membership and duties of the Cannabis Products Advisory Committee, an entity created in the legislation which FDA would convene and consult before promulgating regulations.
• Clarifying market competition rules meant to protect independent retailers and prevent anti-competitive behavior, to ensure that those rules do not unintentionally undermine state programs that provide access to capital for social equity businesses.
• Broad review of agricultural and environmental laws applicable to cannabis, and working to ensure that appropriate environmental protections apply to cannabis production.
• Ensuring worker protections for those employed in the cannabis industry.
• Ensuring regulatory bodies and law enforcement have the resources and tools they need to protect the integrity of the legal cannabis marketplace.
• Strengthening cannabis business protections and opportunities under Small Business Administration programs.
• Clarifying the relationship between state governments and Indian tribal governments with respect to cannabis.
• Broad review of existing law to cannabis throughout the government, and developing a variety of additional policies to ensure consistent and appropriate treatment of cannabis.
“The federal cannabis ban is a senseless and failed relic that’s needlessly destroyed lives, stifled research and treated job-generating legal small businesses in Oregon and other states like criminal organizations,” Wyden said. “This outdated prohibition is long overdue for an end. And introducing final legislation as early as possible requires committees to continue their diligent work, and agencies to provide prompt analysis.”
“Simply put, final text of this urgently needed legislation must be released well before the August recess to continue building momentum for cannabis reform,” he said.
Booker, for his part, said that as more and more states move to legalize cannabis, “Congress must enact comprehensive cannabis reform that will deliver restorative justice to communities to undo the harms of America’s failed drug policies.”
“After months of substantive progress we are close to finalizing a bill that reflects common sense drug policy and delivers long overdue justice,” the senator said.
This development comes weeks after the U.S. House of Representatives approved a separate bill to federally legalize marijuana and promote social equity, the Marijuana Opportunity, Reinvestment and Expungement (MORE) Act from Judiciary Committee Jerrold Nadler (D-NY).
The largely partisan vote on that legislation, which saw only three Republicans vote in favor of passage, speaks to the challenges that a similar Senate bill might face, especially in the draft version released last year.
Meanwhile, several Republican members of Congress introduced a bill last November to federally legalize and tax marijuana as an alternative to far-reaching Democratic-led reform proposals and scaled-down GOP cannabis descheduling legislation. The sponsor of that bill, Rep. Nancy Mace (R-SC), said she expects a committee hearing on her proposal.
On Thursday, a bipartisan group of congressional lawmakers filed a bill that would simply direct the attorney general to create a commission charged with making recommendations on a regulatory system for marijuana that models what’s currently in place for alcohol.
Reps. Dave Joyce (R-OH), Hakeem Jeffries (D-NY) and Brian Mast (R-FL) are teaming up on what’s titled the Preparing Regulators Effectively for a Post-Prohibition Adult-Use Regulated Environment Act (PREPARE) Act—an incremental reform meant to inform comprehensive cannabis policy changes in the future.
Cresco Labs Brings Its FloraCal Farms Brand to Illinois
April 13, 2022
https://investors.crescolabs.com/investors/press-releases/press-release-details/2022/Cresco-Labs-Brings-Its-FloraCal-Farms-Brand-to-Illinois/default.aspx
The premium craft brand arrives with flower, vapes and concentrates available for purchase ahead of 420
CHICAGO--(BUSINESS WIRE)-- Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, today announced the launch of its premium craft brand FloraCal Farms, which features unique genetics in curated flower, live rosin vape and live rosin concentrate formats now available at all Illinois Sunnyside stores and other retailers ahead of the 420 cannabis holiday.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220413005236/en/
Cresco Labs’s premium craft brand FloraCal Farms expands to Illinois with novel, exclusive genetics and flower, vape and concentrates formats. (Photo: Business Wire)
Cresco Labs’s premium craft brand FloraCal Farms expands to Illinois with novel, exclusive genetics and flower, vape and concentrates formats. (Photo: Business Wire)
“FloraCal Farms’ vision is to deliver a first-class experience to sophisticated cannabis consumers who value unique terpene profiles, flower structure and all the fruits of artisanal cultivation and processing methods,” said Charles Bachtell, CEO & Co-Founder of Cresco Labs. “We plan to launch FloraCal Farms in other markets throughout the year to reach the ultra-premium shopper. Along with our Cresco and High Supply brands, our uniquely designed portfolio architecture of tiered inhalable offerings and pricing will allow us to offer a variety of value propositions for consumers and to compete incredibly well in the marketplace.”
Born in Sonoma County, FloraCal Farms continues to honor its California heritage through a commitment to tailored craftsmanship established by wife-and-husband founders Karen and Drew Duval, who oversee commercial sales and cultivation at the Company. FloraCal Farms maintains a rigorous pheno-hunting process that starts with hundreds of plants, then hand-selects only the winning strains to be developed into flower, vapes and hand-crafted concentrates. Flower is always hand-harvested, trimmed and packaged to preserve delicate flower characteristics. Live rosin vapes and concentrates follow solventless extraction processes, an innovative method new to Cresco Labs’ wholesale portfolio that removes the oil containing components from the raw materials simply through ice water and manual agitation – without the use of chemical solvents. The resulting materials are pressed to produce live rosin bursting with the terpenes, flavor and potency that cannabis connoisseurs enjoy.
Available for sale forms at launch in Illinois include hand-trimmed flower (3.5g), live rosin vape cartridges (500mg) and live rosin badder concentrates (1g). More products and exclusive strains will arrive on dispensary shelves throughout the year.
The launch of FloraCal Farms in Illinois rounds out the Company’s wholesale portfolio in Illinois. Other available brands include Cresco, High Supply, Good News, Mindy’s, Wonder Wellness and Remedi.
For more information about FloraCal Farms, visit www.floracalfarms.com. To learn more about Cresco Labs, visit www.crescolabs.com.
About Cresco Labs Inc.
Cresco Labs is one of the largest vertically integrated multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods (“CPG”) approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted national brands including Cresco, High Supply, Mindy's Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, Cresco Labs’ national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry’s largest Social Equity and Educational Development initiative, SEED, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com.
Facebook: Cresco Labs
Instagram: Cresco Labs
Twitter: Cresco Labs
View source version on businesswire.com: https://www.businesswire.com/news/home/20220413005236/en/
Media:
Jason Erkes, Cresco Labs
Chief Communications Officer
press@crescolabs.com
Investors:
Megan Kulick, Cresco Labs
Senior Vice President, Investor Relations
investors@crescolabs.com
For general Cresco Labs inquiries:
312-929-0993
info@crescolabs.com
Source: Cresco Labs Inc.
Wow. Really liking Cresco at these levels
You can’t lose when you spell loose.
"We believe in shared value. When we win, everybody wins." So when you loose, we loose? :(
How are those affirmative action induced board member picks and social justice bullsh@t videos working out? Closing in on a 52 week low that's how. This company whom basically has a monopoly cant pull it together. Mic drop!
We're honored to highlight @CCA_NY and their reintegrative justice initiatives through reduced reliance on incarceration. Learn more and donate at http://crescocannabis.com/socialjustice. 100% of proceeds benefit the organization.
We're honored to highlight @CCA_NY and their reintegrative justice initiatives through reduced reliance on incarceration. Learn more and donate at https://t.co/5aigOgLC1D. 100% of proceeds benefit the organization. pic.twitter.com/w4q8wrsJrT
— Cresco Labs (@crescolabs) February 15, 2022
Cresco Labs Announces Megan Kulick as Senior Vice President Investor Relations
February 15, 2022
https://investors.crescolabs.com/investors/press-releases/press-release-details/2022/CRESCO-LABS-ANNOUNCES-MEGAN-KULICK-AS-SENIOR-VICE-PRESIDENT-INVESTOR-RELATIONS/default.aspx
CHICAGO – February 14, 2022 — Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or “the Company”), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, announced today that Ms. Megan Kulick has been appointed to the role of Senior Vice President of Investor Relations.
“Megan’s experience in the cannabis industry paired with a long and successful career at some of the most prestigious banks and investment managers makes her the perfect fit as the industry evolves and begins to attract more institutional capital,” said Dennis Olis, Cresco Labs’ CFO. “While searching for a new head of IR, Megan’s name was consistently the first recommendation from analysts and institutional investors. We are thrilled to have her as part of the team.”
Ms. Kulick has over 20 years of experience in investor relations, equity research, and portfolio management at bulge bracket U.S. banks and cannabis multi-state operators. Most recently, she led Investor Relations for AYR Wellness Inc. Prior to that she held several senior positions, including the role of Senior Vice President at PIMCO, Director at Merrill Lynch, and VP at JPMorgan Chase. Megan began her career at Merrill Lynch in Equity Research covering Telecommunications Services.
About Cresco Labs Inc.
Cresco Labs is one of the largest vertically integrated multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods (“CPG”) approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted national brands including Cresco, High Supply, Mindy's Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, Cresco Labs’ national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry’s largest Social Equity and Educational Development initiative, SEED, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com.
Forward Looking Statements
This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as, ‘may,’ ‘will,’ ‘should,’ ‘could,’ ‘would,’ ‘expects,’ ‘plans,’ ‘anticipates,’ ‘believes,’ ‘estimates,’ ‘projects,’ ‘predicts,’ ‘potential’ or ‘continue’ or the negative of those forms or other comparable terms. The Company’s forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to those risks discussed under “Risk Factors” in the Company’s Annual Information Form for the year ended December 31, 2020 filed on March 26, 2021, and other documents filed by the Company with Canadian securities regulatory authorities; and other factors, many of which are beyond the control of the Company. Readers are cautioned that the foregoing list of factors is not exhaustive. Because of these uncertainties, you should not place undue reliance on the Company’s forward-looking statements. No assurances are given as to the future trading price or trading volumes of Cresco Labs’ shares, nor as to the Company’s financial performance in future financial periods. The Company does not intend to update any of these factors or to publicly announce the result of any revisions to any of the Company’s forward-looking statements contained herein, whether as a result of new information, any future event or otherwise. Except as otherwise indicated, this press release speaks as of the date hereof. The distribution of this press release does not imply that there has been no change in the affairs of the Company after the date hereof or create any duty or commitment to update or supplement any information provided in this press release or otherwise.
Contacts
Media:
Jason Erkes, Cresco Labs
Chief Communications Officer
press@crescolabs.com
Investors:
Megan Kulick
Senior Vice President Investor Relations
investors@crescolabs.com
For general Cresco Labs inquiries:
312-929-0993
info@crescolabs.com
McConnell already called this out and basically said over my dead body when the bill showed up last week.
Believe it when it happens. Perlmutter"s strategy is to make it a poison pill for republicans. --->>> House Marijuana Banking Bill Sponsor Is ‘Confident’ It Will Advance Through Senate Despite Obstacles
Watch the video here:
“Eight years of my 16 year career I’ve been working on this, since Colorado legalized marijuana back in 2012-2013,” @RepPerlmutter says about the Safe Banking Act. “I am confident that the Senate will take it up.” More: pic.twitter.com/CCeRHzFgcm
— Yahoo Finance (@YahooFinance) February 11, 2022
Cresco Labs Announces Social Justice Documentary to Premiere at Santa Barbara International Film Festival & South by Southwest
February 11, 2022
https://investors.crescolabs.com/investors/press-releases/press-release-details/2022/Cresco-Labs-Announces-Social-Justice-Documentary-to-Premiere-at-Santa-Barbara-International-Film-Festival--South-by-Southwest/default.aspx
CHICAGO--(BUSINESS WIRE)-- Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or “the Company”), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, today announced the Clio Award-winning documentary short film, “The Sentence of Michael Thompson”, will have its world premiere on March 9 at the Santa Barbara International Film Festival (“SBIFF”) and screen March 13 through 17 at the South by Southwest (“SXSW”) film festival. “The Sentence of Michael Thompson” is the first documentary short film on the topic of social justice, criminal justice reform and cannabis decriminalization, and the first social justice-focused documentary produced by a cannabis brand (Cresco), to debut at both acclaimed global and U.S. film festivals held in Santa Barbara, Calif. and Austin, Texas, respectively.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220211005147/en/
“It is humbling and an honor to have the opportunity to help share Michael Thompson’s story through such prestigious film festivals like SBIFF and SXSW,” said Chima Enyia, EVP of SEED at Cresco Labs. “Unfortunately, one of the themes central to Michael’s story is not unique; several hundred thousand Americans—predominantly Black and Latinx—continue to be arrested on marijuana-related charges every year. Over 40,000 people suffer in prison because of cannabis-related convictions at this very moment. Through this film, we hope to help audiences truly understand the gravity of injustice on the lives of people adversely impacted by The War on Drugs and advance the dialogue surrounding racial and social justice to help change our nation’s drug laws.”
The subject of the film, Michael Thompson, is the longest serving non-violent offender in Michigan history. In 1994, he was arrested for selling three pounds of cannabis to a close friend turned police informant. He was sentenced to 42 to 60 years and remained in prison after Michigan legalized the recreational use and sale of cannabis.
“The Sentence of Michael Thompson” follows Michael’s daughter, Rashawnda, and his lawyer, Kim, during the fight for clemency. It examines the harm the War on Drugs has caused on marginalized communities and explores paths forward as national cannabis legalization gets closer to becoming a reality. The filmmaking team includes Kyle Thrash, Haley Elizabeth Anderson, Ian Ross, Logan Triplett and Matt Schaff, who’s work have all been shown at SXSW, Sundance, Tribeca and other notable national and international film festivals. Released on Juneteenth 2021, the film’s trailer earned the Silver Clio Cannabis Award for Film & Video creative excellence.
Over the past 35 years, SBIFF, a nonprofit arts and educational organization, has become one of the leading film festivals in the U.S. The film festival takes place March 2 through 12, 2022. For more information, visit SBIFF.org. Now in its 29th year, SXSW is best known for its conference and festivals that celebrate the convergence of the interactive, film and music industries. The Film Festival runs March 11 through 19, 2022. For more information about the SXSW Film Festival, visit SXSW.com/festivals/film.
To watch “The Sentence of Michael Thompson” trailer and learn more about Cresco’s year-round restorative justice efforts, visit Crescocannabis.com/michaelthompson. For more information about Cresco Labs’ social equity, social justice, education and workforce development initiative, SEEDTM, visit CrescoLabs.com/SEED.
Film Stills & Trailer File can be found HERE.
About Cresco Labs Inc.
Cresco Labs is one of the largest vertically integrated multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods (“CPG”) approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted national brands including Cresco, High Supply, Mindy's Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, Cresco Labs’ national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry’s largest Social Equity and Educational Development initiative, SEED, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com. Follow Cresco Labs on Facebook, Instagram, Twitter and LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220211005147/en/
Media:
Jason Erkes, Cresco Labs
Chief Communications Officer
press@crescolabs.com
Investors:
investors@crescolabs.com
For general Cresco Labs inquiries:
312-929-0993
info@crescolabs.com
Source: Cresco Labs
Surprisingly...Price..$7.01..Day's-Change+0.41(+6.21%)...Nice-bump
Volume(Heavy Day) Today's volume of 399,338 shares is on pace to be much greater than CRLBF's 10-day average volume of 588,111 shares.
February 07, 2022 1:17pm ET
'-Kush-' Today you are spot on.
Cresco killing it,
$$$CL$$$
Cresco Labs Announces 15th Florida Sunnyside Store Opening in North Miami
February 07, 2022
https://investors.crescolabs.com/investors/press-releases/press-release-details/2022/Cresco-Labs-Announces-15th-Florida-Sunnyside-Store-Opening-in-North-Miami/default.aspx
CHICAGO--(BUSINESS WIRE)-- Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or “the Company”), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, announced today the opening of a new Sunnyside dispensary in North Miami, Florida. Sunnyside North Miami, located at 505 NE 125th St., is Cresco Labs’ first location in Miami-Dade County, 15th store in Florida and 49th dispensary nationwide. The Company’s upcoming Lady Lake store will be its 50th in the US.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220207005284/en/
“We’re thrilled to welcome North Miami patients to Sunnyside’s retail experience for the first time,” said Charlie Bachtell, CEO and Co-founder of Cresco Labs. “One of our priorities this year is to expand access to Cresco Labs portfolio of high-quality and diverse cannabis products and to that end we will be opening new dispensaries across Florida all year.”
Sunnyside North Miami is a highly accessible retail location situated on a busy retail corridor and a few blocks away from the heavily trafficked I-95 Expressway and State Road 909. The medical cannabis dispensary will serve patients in Miami-Dade County with simple online ordering and convenient next-day delivery service.
Patients of the new store will have access one of the largest selections of cannabis products and accessories, including One Plant’s top selling, premium, hand-trimmed flower and solventless live rosin concentrates, as well as vape cartridges, pre-rolls, tinctures, lighters, rolling papers and more. Regular store hours are Monday through Saturday, 10 a.m. to 8 p.m., and Sunday, 10 a.m. to 5 p.m.
In addition to the North Miami opening, Cresco Labs serves patients through its Sunnyside dispensaries in Avon Park, Boynton Beach, Orlando (Fern Park), Jacksonville Beach, Ocala, Port St. Lucie, St. Petersburg, Bonita Springs, Fort Lauderdale, Oakland Park, Tallahassee, Pensacola, Sarasota and Clearwater.
For more information about Sunnyside and to place online orders, visit www.sunnyside.shop.
About Cresco Labs Inc.
Cresco Labs is one of the largest vertically integrated multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods (“CPG”) approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted national brands including Cresco, High Supply, Mindy's Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, Cresco Labs’ national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry’s largest Social Equity and Educational Development initiative, SEED, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com.
Forward Looking Statements
This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as, ‘may,’ ‘will,’ ‘should,’ ‘could,’ ‘would,’ ‘expects,’ ‘plans,’ ‘anticipates,’ ‘believes,’ ‘estimates,’ ‘projects,’ ‘predicts,’ ‘potential’ or ‘continue’ or the negative of those forms or other comparable terms. The Company’s forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to those risks discussed under “Risk Factors” in the Company’s Annual Information Form for the year ended December 31, 2020 filed on March 26, 2021, and other documents filed by the Company with Canadian securities regulatory authorities; and other factors, many of which are beyond the control of the Company. Readers are cautioned that the foregoing list of factors is not exhaustive. Because of these uncertainties, you should not place undue reliance on the Company’s forward-looking statements. No assurances are given as to the future trading price or trading volumes of Cresco Labs’ shares, nor as to the Company’s financial performance in future financial periods. The Company does not intend to update any of these factors or to publicly announce the result of any revisions to any of the Company’s forward-looking statements contained herein, whether as a result of new information, any future event or otherwise. Except as otherwise indicated, this press release speaks as of the date hereof. The distribution of this press release does not imply that there has been no change in the affairs of the Company after the date hereof or create any duty or commitment to update or supplement any information provided in this press release or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220207005284/en/
Media:
Jason Erkes, Cresco Labs
Chief Communications Officer
press@crescolabs.com
Investor Relations:
investors@crescolabs.com
For general Cresco Labs inquiries:
312-929-0993
info@crescolabs.com
Source: Cresco Labs
Schumer Plans To File Marijuana Legalization Bill In April As Top House Lawmaker Details His Own Reform Plan
Published 3 hours ago on February 4, 2022
By Kyle Jaeger
Senate Majority Leader Chuck Schumer (D-NY) announced at a press conference on Friday that he is aiming to formally file his much-anticipated bill to federally legalize marijuana in April. House Judiciary Committee Chairman Jerrold Nadler (D-NY), who also spoke, discussed progress on his separate legalization bill.
Both top lawmakers detailed their efforts to end prohibition at an event in New York City, which also involved House Small Business Committee Chairwoman Nydia Velazquez (D-NY), New York lawmakers and advocates with the Drug Policy Alliance and other organizations.
Friday proved to be an especially eventful day for federal cannabis policy, as the House earlier passed a large-scale bill that contains the bipartisan Secure and Fair Enforcement (SAFE) Banking Act. It’s the sixth time that reform has cleared the chamber in some form.
“In the coming weeks, we’re ramping up our outreach—and we expect to introduce final legislation. Our goal is to do it in April,” Schumer said at the New York event. “Then we begin the nationwide push, spearheaded by New York, to get the federal law done. As majority leader, I can set priorities. This is a priority for me.”
Advocates were encouraged when Schumer first disclosed details about his Cannabis Administration & Opportunity Act (CAOA), which he unveiled in draft form for public comment in July, but they’ve grown impatient with his repeated comments in the months since that a formal introduction was coming “soon.” Now he’s set a target timeline, and the leader also separately said in a meeting with activists that he expects committee hearings on the proposal shortly after it’s finally filed.
“Right now, we’re taking those comments [on the draft version] and reaching out to Democratic and Republican senators,” Schumer said, adding that “we have some Republican support.” It’s not clear if he’s indicating that there will be GOP cosponsors on the bill itself or if he’s referencing general support from voters and some lawmakers across party lines for ending prohibition.
“If any senators have other ideas that they want to add to the bill, as long as it keeps social and economic justice as the spearhead, we’re happy and willing to listen,” he said.
Even if committee hearings start quickly following an April introduction, it seems highly unlikely that it will pass and make it to the president’s desk by the unofficial cannabis holiday 4/20, as Schumer said he wanted to see happen in a Senate floor speech delivered last April 20.
Schumer, Nadler, several New York lawmakers also made the case at Friday’s event that while New York’s legalization law, which is actively being implemented, should serve as a model for the country, comprehensive equity will only be achievable once federal prohibition is lifted.
“We want to renew the case for comprehensive marijuana reform that repairs the harm of the war on drugs at the federal level, using the great work that has been done here in New York as an example and way to lead,” Schumer said, adding that “just because we have a state law, the federal law still creates problems, and that’s why one of the many reasons we need to change it.”
The majority leader’s office has been involved in negotiations with advocates and stakeholders, both on his legalization measure as well as the SAFE Banking Act, which he was blamed for blocking as part of a separate defense bill late last year.
The leader and colleagues have insisted on passing comprehensive legalization first before banking—but the sponsor of the banking bill, Rep. Ed Perlmutter (D-CO), told Marijuana Moment on Friday that, after initiating conversations with the leader’s office, there may be a path forward to advance his legislation through both chambers with equity-focused amendments that Schumer wants to see.
With respect to Schumer’s legalization bill, the Senate leader emphasized late last year that he wants to keep the “big boys” out of the marijuana industry in favor of creating opportunities for smaller operators when cannabis is federally legalized, and he said that his upcoming bill would accomplish that.
“We don’t want the big boys to come in,” he said at the time. “After all the pain that’s been occurring in communities like the one you represent in Brooklyn, where I’m from—to have the big boys come in and make all the money makes no sense.”
He’s made similar remarks in the past, stressing that his reform bill will take specific steps to restrict the ability of large alcohol and tobacco companies to overtake the industry.
Nadler, meanwhile, discussed on Friday his Marijuana Opportunity, Reinvestment and Expungement (MORE) Act, which would also end federal prohibition and promote social equity in the industry like CAOA. That bill passed the House in a historic first last session, and it cleared Nadler’s Judiciary Committee again in September.
“The war on drugs—and particularly the criminalization of marijuana—has been a failure that has unleashed untold suffering on millions of Americans, especially within minority communities,” Nadler said. “I am proud to stand here with Senator Schumer, and with the many other legislators and advocates with us today, who are leading the way in reforming our laws and bringing justice to those who have been harmed by these unfair and destructive policies.”
Also at the event, Velazquez talked about the importance of ending prohibition, as well as opening up Small Business Administration (SBA) resources for marijuana businesses.
“Change will not happen, change will not come, unless we demand it,” the congresswoman said. “And because we have been demanding it, public opinion has changed dramatically. So it is time for government to act, particularly the federal government.”
Dan Goldman contributed reporting from New York.
endless hope for that by everyone in the sector.......safe banking is back in the house of reps for like the 6th time . TBC.....
Any chance of this upleveling off the OTC?
Cresco Labs Announces Launch of Khalifa Kush Products at Cookies Dispensaries Throughout California
https://investors.crescolabs.com/investors/press-releases/press-release-details/2022/Cresco-Labs-Announces-Launch-of-Khalifa-Kush-Products-at-Cookies-Dispensaries-Throughout-California/default.aspx
January 28, 2022
Wiz Khalifa’s bestselling cannabis brand expanded to California through an exclusive cultivation & product collaboration with the Company’s FloraCal Farms and Continuum platform
CHICAGO--(BUSINESS WIRE)-- Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or “the Company”), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, today announced flower and pre-rolls from Khalifa Kush are available for sale at Cookies stores throughout California. Cresco Labs has an exclusive cultivation and product collaboration agreement with multi-platinum-selling, GRAMMY® and Golden Globe® Award-nominated recording artist Wiz Khalifa’s cannabis brand. Through the partnership, the Company’s FloraCal Farms and Continuum distribution platform will be the sole producer and distributor, respectively, of premium branded products featuring Khalifa Kush’s signature “KK” strain in California. An expanded line is expected to arrive at additional retail partners throughout the year.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220128005052/en/
Through a cultivation & product collaboration partnership with Cresco Labs’ FloraCal Farms and Continuum, flower and pre-rolls from Khalifa Kush are now for sale at Cookies stores throughout California. (Photo: Business Wire)
Through a cultivation & product collaboration partnership with Cresco Labs’ FloraCal Farms and Continuum, flower and pre-rolls from Khalifa Kush are now for sale at Cookies stores throughout California. (Photo: Business Wire)
“Wiz Khalifa has been a longtime advocate for cannabis legalization, with a namesake OG strain beloved by many in other states. Today, we’re thrilled to bring his brand to cannabis lovers and his fans in California,” said David Gacom, West Region Regional President at Cresco Labs. “We’re focused on bringing a curated portfolio of leading brands to California retailers, and Khalifa Kush is a natural addition with its focus on delivering top quality cannabis. We’re excited to work with the talented Khalifa Kush team to grow its cannabis and commercialize its products.”
"We're excited to launch Khalifa Kush in California with Cresco Labs; we've been working for years on this project." said Wiz Khalifa. "The KK grown at FloraCal is the best I've smoked, and I’m excited for the people of California to enjoy the original KK."
“FloraCal Farms and Continuum, with their best-in-class cultivation capabilities and significant scale and penetration, have proven to be the premier cultivator and distribution platform in the largest and most competitive market in the country, and we’re honored to partner with their teams to expand Khalifa Kush’s footprint in California,” said DJ Saul, CEO of Khalifa Kush.
About Cresco Labs Inc.
Cresco Labs is one of the largest vertically integrated multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods (“CPG”) approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted national brands including Cresco, High Supply, Mindy's Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, Cresco Labs’ national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry’s largest Social Equity and Educational Development initiative, SEED, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com. Follow Cresco Labs on Facebook, Instagram, Twitter and LinkedIn.
About Khalifa Kush
Khalifa Kush products were first commercialized in the U.S. in 2015 by global icon Wiz Khalifa. The company has achieved continued growth and success by focusing on high quality and highly sought-after products in legalized cannabis markets. The Khalifa Kush brand offers a growing lineup of flower, pre-rolls, vapes, edibles, and concentrates, powered by proprietary genetics, in partnership with Compound Genetics. Khalifa Kush is available in select markets including Nevada, Arizona and Utah. Learn more about the upcoming California launch, Michigan launch and shop apparel at KHALIFAKUSH.COM.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220128005052/en/
Media:
Jason Erkes, Cresco Labs
Chief Communications Officer
press@crescolabs.com
Investors:
investors@crescolabs.com
Khalifa Kush / Wiz Khalifa press:
Dvora Englefield Dvora.Englefield@ledecompany.com
Courtni Asbury Courtni.Asbury@ledecompany.com
Chris Iacullo Chris.Iacullo@ledecompany.com
For general Cresco Labs inquiries:
312-929-0993
info@crescolabs.com
Source: Cresco Labs
Cresco Labs Expands Sunnyside in Florida’s Gulf Coast With New Clearwater Dispensary
https://investors.crescolabs.com/investors/press-releases/press-release-details/2022/Cresco-Labs-Expands-Sunnyside-in-Floridas-Gulf-Coast-With-New-Clearwater-Dispensary/default.aspx
January 27, 2022
IMO, I really don't understand why they are investing in Florida when their are rec legal states available to them. They are making very little impact in FLA, so the ROI can't be as high as elsewhere? - FUNMAN
https://knowthefactsmmj.com/wp-content/uploads/ommu_updates/2022/012122-OMMU-Update.pdf
Agreed. Now is the time to bring cash flow positive from your own operations.
My gut reaction is that Blair Wellness didn't meet all of the deal's terms because they were probably trying to hide something that would have valued the business for less, or their accounting showed irregularities.
The transparency wasn't there to justify the price or worth renegotiating.
It's a mature move by CRESCO to walk away.
Funman, what are your thoughts on this termination of agreement...Good? Bad? Neutral?
Cresco Labs Announces Termination of Blair Wellness Acquisition
January 19, 2022
https://investors.crescolabs.com/investors/press-releases/press-release-details/2022/Cresco-Labs-Announces-Termination-of-Blair-Wellness-Acquisition/default.aspx
CHICAGO--(BUSINESS WIRE)-- Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or “the Company”), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, announced today the termination of the previously announced definitive agreement to acquire 100% of the outstanding equity interest in Blair Wellness, LLC (“Blair Wellness”), a Baltimore Maryland medical cannabis dispensary (the “Transaction”).
“We have terminated the purchase agreement with Blair Wellness due to the failure of certain closing conditions to be met prior to our specified termination date,” said Charlie Bachtell, Cresco Labs’ CEO & Co-founder. “We will continue to look for other avenues to expand our footprint in Maryland, and execute our strategy of going deep in meaningful, material states.”
Blair Wellness was originally expected to close during Q4 2021. There are no termination fees associated with the Transaction.
About Cresco Labs Inc.
Cresco Labs is one of the largest vertically integrated multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods (“CPG”) approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted national brands including Cresco, High Supply, Mindy's Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, Cresco Labs’ national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry’s largest Social Equity and Educational Development initiative, SEED, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com.
Forward Looking Statements
This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as, ‘may,’ ‘will,’ ‘should,’ ‘could,’ ‘would,’ ‘expects,’ ‘plans,’ ‘anticipates,’ ‘believes,’ ‘estimates,’ ‘projects,’ ‘predicts,’ ‘potential’ or ‘continue’ or the negative of those forms or other comparable terms. The Company’s forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to those risks discussed under “Risk Factors” in the Company’s Annual Information Form for the year ended December 31, 2020 filed on March 26, 2021, and other documents filed by the Company with Canadian securities regulatory authorities; and other factors, many of which are beyond the control of the Company. Readers are cautioned that the foregoing list of factors is not exhaustive. Because of these uncertainties, you should not place undue reliance on the Company’s forward-looking statements. No assurances are given as to the future trading price or trading volumes of Cresco Labs’ shares, nor as to the Company’s financial performance in future financial periods. The Company does not intend to update any of these factors or to publicly announce the result of any revisions to any of the Company’s forward-looking statements contained herein, whether as a result of new information, any future event or otherwise. Except as otherwise indicated, this press release speaks as of the date hereof. The distribution of this press release does not imply that there has been no change in the affairs of the Company after the date hereof or create any duty or commitment to update or supplement any information provided in this press release or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220119005457/en/
Media:
Jason Erkes, Cresco Labs
Chief Communications Officer
press@crescolabs.com
Investors:
investors@crescolabs.com
For general Cresco Labs inquiries:
312-929-0993
info@crescolabs.com
Source: Cresco Labs
Cresco Labs Announces Opening of 10th Pennsylvania Dispensary in Ambler
January 18, 2022
CHICAGO--(BUSINESS WIRE)-- Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or “the Company”), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, is expanding its Sunnyside brand in Pennsylvania with a new store located at 28 W Skippack Pike in Ambler. This location becomes the Company’s 10th store in Pennsylvania and 47th dispensary nationwide.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220118005232/en/
“We are thrilled to be opening our 10th store in Pennsylvania, a continuation of our strategy of going deeper in our footprint and tailoring to individual state dynamics,” said Charlie Bachtell, Cresco Labs’ CEO & Co-founder. “With our CPG and wholesale focus, we’ve been able to take the top market share in Pennsylvania according to Headset. Adding additional fully-owned retail will support our brand building and provide more access to Cresco Labs’ amazing products for patients across Pennsylvania.”
Located in the borough of Ambler north of Philadelphia, the dispensary is a few miles away from the Pennsylvania Turnpike, a superhighway transporting thousands of people daily east-west across the state. Sunnyside Ambler resides in an area home to large facilities operated by major pharmaceutical companies, including Johnson & Johnson, Merck and Janssen.
The dispensary will be open Monday through Thursday, 9 a.m. to 6 p.m., and Friday and Saturday, 9 a.m. to 7 p.m. Patients can place online orders, browsing live inventory, on www.Sunnyside.shop and pick up orders in-store the same day. Store phone is 267-405-2622.
For more information about Sunnyside, visit www.sunnyside.shop.
About Cresco Labs Inc.
Cresco Labs is one of the largest vertically integrated multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods (“CPG”) approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted national brands including Cresco, High Supply, Mindy's Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, Cresco Labs’ national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry’s largest Social Equity and Educational Development initiative, SEED, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com.
Forward Looking Statements
This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as, ‘may,’ ‘will,’ ‘should,’ ‘could,’ ‘would,’ ‘expects,’ ‘plans,’ ‘anticipates,’ ‘believes,’ ‘estimates,’ ‘projects,’ ‘predicts,’ ‘potential’ or ‘continue’ or the negative of those forms or other comparable terms. The Company’s forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to those risks discussed under “Risk Factors” in the Company’s Annual Information Form for the year ended December 31, 2020 filed on March 26, 2021, and other documents filed by the Company with Canadian securities regulatory authorities; and other factors, many of which are beyond the control of the Company. Readers are cautioned that the foregoing list of factors is not exhaustive. Because of these uncertainties, you should not place undue reliance on the Company’s forward-looking statements. No assurances are given as to the future trading price or trading volumes of Cresco Labs’ shares, nor as to the Company’s financial performance in future financial periods. The Company does not intend to update any of these factors or to publicly announce the result of any revisions to any of the Company’s forward-looking statements contained herein, whether as a result of new information, any future event or otherwise. Except as otherwise indicated, this press release speaks as of the date hereof. The distribution of this press release does not imply that there has been no change in the affairs of the Company after the date hereof or create any duty or commitment to update or supplement any information provided in this press release or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220118005232/en/
Media:
Jason Erkes, Cresco Labs
Chief Communications Officer
press@crescolabs.com
Investors:
investors@crescolabs.com
For general Cresco Labs inquiries:
312-929-0993
info@crescolabs.com
Source: Cresco Labs Inc.
Little over a 1/2 hr from my home. :) Nice setup.
Cresco Labs Announces Conference Participation for January 2022
January 06, 2022
https://investors.crescolabs.com/investors/press-releases/press-release-details/2022/Cresco-Labs-Announces-Conference-Participation-for-January-2022/default.aspx
CHICAGO--(BUSINESS WIRE)-- Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or “the Company”), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, today announced its executive team will participate in the following conferences in January 2022:
ATB 10th Annual Institutional Investor Conference, January 13, 2022:
Chief Commercial Officer, Greg Butler will participate in a panel discussion and management will participate in one-on-one meetings.
Details on the panel are shown below:
Title: Brand Building and Leadership: The Good, The Bad, The Ugly
Date: Thursday, January 13, 2022
Time: 9:00 a.m. ET
Webcast Link: https://bit.ly/3pY9tLv
24th Annual Needham Virtual Growth Conference, January 14, 2022:
Management will participate in one-on-one meetings.
About Cresco Labs Inc.
Cresco Labs is one of the largest vertically integrated multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods (“CPG”) approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted national brands including Cresco, High Supply, Mindy's Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, Cresco Labs’ national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry’s largest Social Equity and Educational Development initiative, SEED, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com.
Facebook: Cresco Labs
Instagram: Cresco Labs
Twitter: Cresco Labs
View source version on businesswire.com: https://www.businesswire.com/news/home/20220106005179/en/
Media:
Jason Erkes, Cresco Labs
Chief Communications Officer
press@crescolabs.com
Investors:
investors@crescolabs.com
For general Cresco Labs inquiries:
312-929-0993
info@crescolabs.com
Source: Cresco Labs
Cresco Labs Announces Opening of 45th Nationwide Dispensary in Sarasota, FL
December 17, 2021
https://investors.crescolabs.com/investors/press-releases/press-release-details/2021/Cresco-Labs-Announces-Opening-of-45th-Nationwide-Dispensary-in-Sarasota-FL/default.aspx
CHICAGO--(BUSINESS WIRE)-- Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or “the Company”), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, is expanding its Sunnyside brand in southwest Florida with a new store located at 8307 Lockwood Ridge Rd. in Sarasota. Sunnyside Sarasota marks Cresco Labs’ 13th Florida location and 45th nationwide store.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211217005060/en/
“We are excited to open Sunnyside Sarasota to continue to expand access to our branded products for Florida patients,” said Charlie Bachtell, Cresco Labs’ CEO & Co-founder. “This is our fifth new dispensary since entering Florida in April, and we expect to continue to expand across the state in the New Year so more patients have access to our products, which have proven to be some of the most popular in other states.”
Sunnyside Sarasota is centrally located in the city between Interstate 75 and the Sarasota Bradenton International Airport. The store is in University Square Plaza, one of Sarasota’s busiest shopping areas. Sarasota is renowned for its cultural institutes, notably the Ringling Museum of Art. It’s also the gateway to miles of beaches, such as Lido Beach and Siesta Key Beach.
Registered patients with a medical card have the option to place orders online through the Sunnyside.shop website or utilize next-day delivery. Delivery orders can be placed in store or by phone at 877-395-1009. Patients can also visit Sunnyside Sarasota to speak with wellness advisors for purchasing assistance. Regular store hours are Monday through Saturday, 10 a.m. to 8 p.m., and Sunday, 10 a.m. to 5 p.m. For more information about Sunnyside, visit www.sunnyside.shop.
About Cresco Labs Inc.
Cresco Labs is one of the largest vertically integrated multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods (“CPG”) approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted national brands including Cresco, High Supply, Mindy's Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, Cresco Labs’ national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry’s largest Social Equity and Educational Development initiative, SEED, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com.
Forward-Looking Statements
This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as, ‘may,’ ‘will,’ ‘should,’ ‘could,’ ‘would,’ ‘expects,’ ‘plans,’ ‘anticipates,’ ‘believes,’ ‘estimates,’ ‘projects,’ ‘predicts,’ ‘potential’ or ‘continue’ or the negative of those forms or other comparable terms. The Company’s forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to those risks discussed under “Risk Factors” in the Company’s Annual Information Form for the year ended December 31, 2020 filed on March 26, 2021, and other documents filed by the Company with Canadian securities regulatory authorities; and other factors, many of which are beyond the control of the Company. Readers are cautioned that the foregoing list of factors is not exhaustive. Because of these uncertainties, you should not place undue reliance on the Company’s forward-looking statements. No assurances are given as to the future trading price or trading volumes of Cresco Labs’ shares, nor as to the Company’s financial performance in future financial periods. The Company does not intend to update any of these factors or to publicly announce the result of any revisions to any of the Company’s forward-looking statements contained herein, whether as a result of new information, any future event or otherwise. Except as otherwise indicated, this press release speaks as of the date hereof. The distribution of this press release does not imply that there has been no change in the affairs of the Company after the date hereof or create any duty or commitment to update or supplement any information provided in this press release or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211217005060/en/
Media:
Jason Erkes, Cresco Labs
Chief Communications Officer
press@crescolabs.com
Investors:
investors@crescolabs.com
For general Cresco Labs inquiries:
312-929-0993
info@crescolabs.com
Source: Cresco Labs Inc.
i.e. like a house closing.
retired early Monday, 12/13/21 10:24:36 AM
Re: FUNMAN post# 2970
Post # 2971 of 2971
How does closing a place we just bought, help us? :)
FUNMAN Friday, 12/10/21 10:14:39 AM
Re: RangerPete post# 2969
Post # 2970 of 2971
Cresco Labs Closes Acquisition of Pennsylvania Vertically Integrated Clinical Registrant, Laurel Harvest
December 10, 2021
https://investors.crescolabs.com/investors/press-releases/press-release-details/2021/Cresco-Labs-Closes-Acquisition-of-Pennsylvania-Vertically-Integrated-Clinical-Registrant-Laurel-Harvest/default.aspx
CHICAGO--(BUSINESS WIRE)-- Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or “the Company”), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, announced today the closing of the Company’s previously announced acquisition of Laurel Harvest Labs, LLC (“Laurel Harvest” or the “Transaction”). Laurel Harvest is a Pennsylvania Clinical Registrant.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211210005044/en/
Transaction Highlights
Approximately 52,000 sq. ft. of indoor grow/processing space
Foundation for an additional 52,000 sq. ft. of indoor cultivation space
One operational dispensary in Montgomeryville
A second dispensary in Scranton is currently under construction
Ability to open an additional four dispensaries throughout the state
“Between the acquisition of Laurel Harvest and the previously closed Cure Penn acquisition, we are executing our strategy of strategic breadth and depth, focused on the most important states, and positioning ourselves to capitalize on the eventual expansion of the cannabis program in Pennsylvania,” said Charlie Bachtell, Cresco Labs’ CEO & Co-founder. “We are tailoring our strategy to the unique dynamics of each state to maintain our leading market position and increase profitability. It is imperative for us to maximize our retail presence and add a second cultivation facility to optimize product quality, assortment and accessibility to maintain the number one wholesale market share in the state1. We’re very excited to further develop the research platform with Temple University as a key component of our mission to normalize and professionalize the industry – a responsible industry creates a respectable industry which, in turn, creates a robust cannabis industry.”
Laurel Harvest Clinical Registrant Highlights
One of eight original Chapter 20 licenses in Pennsylvania
Academic clinical research partnership with Lewis Katz School of Medicine at Temple University
Six current ongoing cannabis research studies
About Cresco Labs Inc.
Cresco Labs is one of the largest vertically integrated multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods (“CPG”) approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted national brands including Cresco, High Supply, Mindy's Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, Cresco Labs’ national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry’s largest Social Equity and Educational Development initiative, SEED, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com.
Forward Looking Statements
This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as, ‘may,’ ‘will,’ ‘should,’ ‘could,’ ‘would,’ ‘expects,’ ‘plans,’ ‘anticipates,’ ‘believes,’ ‘estimates,’ ‘projects,’ ‘predicts,’ ‘potential’ or ‘continue’ or the negative of those forms or other comparable terms. The Company’s forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to those risks discussed under “Risk Factors” in the Company’s Annual Information Form for the year ended December 31, 2020 filed on March 26, 2021, and other documents filed by the Company with Canadian securities regulatory authorities; and other factors, many of which are beyond the control of the Company. Readers are cautioned that the foregoing list of factors is not exhaustive. Because of these uncertainties, you should not place undue reliance on the Company’s forward-looking statements. No assurances are given as to the future trading price or trading volumes of Cresco Labs’ shares, nor as to the Company’s financial performance in future financial periods. The Company does not intend to update any of these factors or to publicly announce the result of any revisions to any of the Company’s forward-looking statements contained herein, whether as a result of new information, any future event or otherwise. Except as otherwise indicated, this press release speaks as of the date hereof. The distribution of this press release does not imply that there has been no change in the affairs of the Company after the date hereof or create any duty or commitment to update or supplement any information provided in this press release or otherwise.
____________________
1 Source: Headset
View source version on businesswire.com: https://www.businesswire.com/news/home/20211210005044/en/
Media:
Jason Erkes, Cresco Labs
Chief Communications Officer
press@crescolabs.com
Investors:
investors@crescolabs.com
For general Cresco Labs inquiries:
312-929-0993
info@crescolabs.com
Source: Cresco Labs
How does closing a place we just bought, help us? :)
Cresco Labs Closes Acquisition of Pennsylvania Vertically Integrated Clinical Registrant, Laurel Harvest
December 10, 2021
https://investors.crescolabs.com/investors/press-releases/press-release-details/2021/Cresco-Labs-Closes-Acquisition-of-Pennsylvania-Vertically-Integrated-Clinical-Registrant-Laurel-Harvest/default.aspx
CHICAGO--(BUSINESS WIRE)-- Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or “the Company”), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, announced today the closing of the Company’s previously announced acquisition of Laurel Harvest Labs, LLC (“Laurel Harvest” or the “Transaction”). Laurel Harvest is a Pennsylvania Clinical Registrant.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211210005044/en/
Transaction Highlights
Approximately 52,000 sq. ft. of indoor grow/processing space
Foundation for an additional 52,000 sq. ft. of indoor cultivation space
One operational dispensary in Montgomeryville
A second dispensary in Scranton is currently under construction
Ability to open an additional four dispensaries throughout the state
“Between the acquisition of Laurel Harvest and the previously closed Cure Penn acquisition, we are executing our strategy of strategic breadth and depth, focused on the most important states, and positioning ourselves to capitalize on the eventual expansion of the cannabis program in Pennsylvania,” said Charlie Bachtell, Cresco Labs’ CEO & Co-founder. “We are tailoring our strategy to the unique dynamics of each state to maintain our leading market position and increase profitability. It is imperative for us to maximize our retail presence and add a second cultivation facility to optimize product quality, assortment and accessibility to maintain the number one wholesale market share in the state1. We’re very excited to further develop the research platform with Temple University as a key component of our mission to normalize and professionalize the industry – a responsible industry creates a respectable industry which, in turn, creates a robust cannabis industry.”
Laurel Harvest Clinical Registrant Highlights
One of eight original Chapter 20 licenses in Pennsylvania
Academic clinical research partnership with Lewis Katz School of Medicine at Temple University
Six current ongoing cannabis research studies
About Cresco Labs Inc.
Cresco Labs is one of the largest vertically integrated multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods (“CPG”) approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted national brands including Cresco, High Supply, Mindy's Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, Cresco Labs’ national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry’s largest Social Equity and Educational Development initiative, SEED, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com.
Forward Looking Statements
This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as, ‘may,’ ‘will,’ ‘should,’ ‘could,’ ‘would,’ ‘expects,’ ‘plans,’ ‘anticipates,’ ‘believes,’ ‘estimates,’ ‘projects,’ ‘predicts,’ ‘potential’ or ‘continue’ or the negative of those forms or other comparable terms. The Company’s forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to those risks discussed under “Risk Factors” in the Company’s Annual Information Form for the year ended December 31, 2020 filed on March 26, 2021, and other documents filed by the Company with Canadian securities regulatory authorities; and other factors, many of which are beyond the control of the Company. Readers are cautioned that the foregoing list of factors is not exhaustive. Because of these uncertainties, you should not place undue reliance on the Company’s forward-looking statements. No assurances are given as to the future trading price or trading volumes of Cresco Labs’ shares, nor as to the Company’s financial performance in future financial periods. The Company does not intend to update any of these factors or to publicly announce the result of any revisions to any of the Company’s forward-looking statements contained herein, whether as a result of new information, any future event or otherwise. Except as otherwise indicated, this press release speaks as of the date hereof. The distribution of this press release does not imply that there has been no change in the affairs of the Company after the date hereof or create any duty or commitment to update or supplement any information provided in this press release or otherwise.
____________________
1 Source: Headset
View source version on businesswire.com: https://www.businesswire.com/news/home/20211210005044/en/
Media:
Jason Erkes, Cresco Labs
Chief Communications Officer
press@crescolabs.com
Investors:
investors@crescolabs.com
For general Cresco Labs inquiries:
312-929-0993
info@crescolabs.com
Source: Cresco Labs
Very nice, and good for Cresco. Now if we could just use that to increase the share price……
Cresco Labs Wins Clio Cannabis Award for Social Justice Documentary
December 08, 2021
https://investors.crescolabs.com/investors/press-releases/press-release-details/2021/Cresco-Labs-Wins-Clio-Cannabis-Award-for-Social-Justice-Documentary/default.aspx
“The Sentence of Michael Thompson” trailer earned a Silver Clio for creative excellence in film/video
CHICAGO--(BUSINESS WIRE)-- Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or “the Company”), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, today announced “The Sentence of Michael Thompson” documentary trailer earned a Silver Clio for Film & Video from the Clio Cannabis Awards. In addition, the Discover Some Wonder podcast series from the Company’s Wonder Wellness cannabis brand and the #Wayto420 campaign from its Sunnyside retail brand were shortlisted for Digital & Mobile and Public Relations creative excellence, respectively.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211208005677/en/
“The Sentence of Michael Thompson” documentary trailer earned a Silver Clio from the 2021 Clio Cannabis Awards, the most prestigious program honoring marketing & communications work. (Graphic: Business Wire)
“The Sentence of Michael Thompson” documentary trailer earned a Silver Clio from the 2021 Clio Cannabis Awards, the most prestigious program honoring marketing & communications work. (Graphic: Business Wire)
Expanding on Clio’s longstanding reputation for establishing best-in-class programs honoring creative excellence in a variety of specialized verticals, the Clio Cannabis Awards—now in its third year—honors work and talent that builds a greater understanding of a rapidly growing industry.
“It is an honor for our efforts to be recognized for the second consecutive year by such a prestigious platform. Top recognition for ‘The Sentence of Michael Thompson’ is very special because social equity and social justice are core to the company’s mission, and the film aims to help people truly understand the gravity of the impact of injustice on the lives of people adversely impacted by The War on Drugs,” said Cory Rothschild, SVP of Marketing.
Chima Enyia, EVP of SEED, added, “We appreciate all those involved—Michael Thompson, his family, restorative justice partners and our staff—in the making of this film. More than 40,000 Americans remain in prison for cannabis offenses, and there is much more work to do to right the wrongs of The War on Drugs. We are laser-focused on leveraging our platform and influence to drive awareness of Michael’s story to ensure conversations about legalization address pardoning those currently incarcerated for cannabis offenses and social equity in the cannabis industry.”
On Juneteenth, Cresco released the trailer for “The Sentence of Michael Thompson”, a documentary short film about the story of Michigan’s longest-serving non-violent offender. Granted clemency this past January, Thompson was serving a 60-year sentence in Muskegon Correctional Facility in Michigan for selling 3 pounds of cannabis to a police informant in 1994. The trailer earned the Silver Clio for Film & Video. The documentary will be released in 2022.
Launched in August for National Wellness Month, Wonder Wellness created a one-of-a-kind audio collection designed to help listeners Focus, Relax, Laugh or Sleep, the experiences delivered by its gummy and minis products. The Discover Some Wonder initiative was named a shortlist winner for Digital & Mobile.
Timed with this year’s 420 holiday, Sunnyside released the results of a nationwide survey that demonstrated shifting beliefs and behaviors surrounding cannabis use and translated them into approachable messages about the plant’s functional benefits for every type of consumer. The #Wayto420 campaign was shortlisted in the Public Relations category.
To view the full gallery of winning work, visit www.cliocannabisawards.com.
About Cresco Labs Inc.
Cresco Labs is one of the largest vertically integrated multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods (“CPG”) approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted national brands including Cresco, High Supply, Mindy's Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, Cresco Labs’ national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry’s largest Social Equity and Educational Development initiative, SEED, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com.
Forward Looking Statements
This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as, ‘may,’ ‘will,’ ‘should,’ ‘could,’ ‘would,’ ‘expects,’ ‘plans,’ ‘anticipates,’ ‘believes,’ ‘estimates,’ ‘projects,’ ‘predicts,’ ‘potential’ or ‘continue’ or the negative of those forms or other comparable terms. The Company’s forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to those risks discussed under “Risk Factors” in the Company’s Annual Information Form for the year ended December 31, 2020 filed on March 26, 2021, and other documents filed by the Company with Canadian securities regulatory authorities; and other factors, many of which are beyond the control of the Company. Readers are cautioned that the foregoing list of factors is not exhaustive. Because of these uncertainties, you should not place undue reliance on the Company’s forward-looking statements. No assurances are given as to the future trading price or trading volumes of Cresco Labs’ shares, nor as to the Company’s financial performance in future financial periods. The Company does not intend to update any of these factors or to publicly announce the result of any revisions to any of the Company’s forward-looking statements contained herein, whether as a result of new information, any future event or otherwise. Except as otherwise indicated, this press release speaks as of the date hereof. The distribution of this press release does not imply that there has been no change in the affairs of the Company after the date hereof or create any duty or commitment to update or supplement any information provided in this press release or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211208005677/en/
Media:
Jason Erkes, Cresco Labs
Chief Communications Officer
press@crescolabs.com
Investor Relations:
investors@crescolabs.com
For general Cresco Labs inquiries:
312-929-0993
info@crescolabs.com
Source: Cresco Labs
Cresco Labs Announces Opening of 44th Dispensary in Pensacola, FL
December 07, 2021
https://investors.crescolabs.com/investors/press-releases/press-release-details/2021/Cresco-Labs-Announces-Opening-of-44th-Dispensary-in-Pensacola-FL/default.aspx
CHICAGO--(BUSINESS WIRE)-- Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or “the Company”), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, announced today the opening of a new Sunnyside dispensary located at 3900 N 9th Ave. in Pensacola, FL. Sunnyside Pensacola is the Company’s second store in the Panhandle region. With today’s opening, Cresco Labs operates 12 Florida stores and 44 nationwide.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211207005308/en/
Cresco Labs’ new Pensacola dispensary is its second in Florida’s Panhandle and 44th nationwide. (Photo: Business Wire)
Cresco Labs’ new Pensacola dispensary is its second in Florida’s Panhandle and 44th nationwide. (Photo: Business Wire)
“This is our fourth Florida new store opening since the closing of the Bluma Wellness acquisition, and we’re on target to double our store count in the state by the anniversary date,” said Charlie Bachtell, CEO and Co-founder of Cresco Labs. “We’re going deeper and expanding accessibility to our branded products in the two biggest medical markets, Florida and Pennsylvania. We’re already the top seller of branded cannabis in Pennsylvania, and we’re excited to expand access to those same amazing products to patients throughout Florida.”
Sunnyside Pensacola is centrally located in the city near Cordova Mall, across the bridge from Pensacola Beach and the suburb of Gulf Breeze, and a few blocks away from Interstate 110—offering broad accessibility to daily commuters and residents.
The store will serve patients with a medical card issued by the state of Florida. Patients can place orders online through the Sunnyside.shop website or utilize next-day delivery. Orders can also be placed both in-store or via phone at 877-395-1009. Regular store hours are Monday through Saturday, 10AM to 8PM, and Sunday, 10AM to 5PM.
About Cresco Labs Inc.
Cresco Labs is one of the largest vertically integrated multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods (“CPG”) approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted national brands including Cresco, High Supply, Mindy's Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, Cresco Labs’ national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry’s largest Social Equity and Educational Development initiative, SEED, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com.
Forward Looking Statements
This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as, ‘may,’ ‘will,’ ‘should,’ ‘could,’ ‘would,’ ‘expects,’ ‘plans,’ ‘anticipates,’ ‘believes,’ ‘estimates,’ ‘projects,’ ‘predicts,’ ‘potential’ or ‘continue’ or the negative of those forms or other comparable terms. The Company’s forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to those risks discussed under “Risk Factors” in the Company’s Annual Information Form for the year ended December 31, 2020 filed on March 26, 2021, and other documents filed by the Company with Canadian securities regulatory authorities; and other factors, many of which are beyond the control of the Company. Readers are cautioned that the foregoing list of factors is not exhaustive. Because of these uncertainties, you should not place undue reliance on the Company’s forward-looking statements. No assurances are given as to the future trading price or trading volumes of Cresco Labs’ shares, nor as to the Company’s financial performance in future financial periods. The Company does not intend to update any of these factors or to publicly announce the result of any revisions to any of the Company’s forward-looking statements contained herein, whether as a result of new information, any future event or otherwise. Except as otherwise indicated, this press release speaks as of the date hereof. The distribution of this press release does not imply that there has been no change in the affairs of the Company after the date hereof or create any duty or commitment to update or supplement any information provided in this press release or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211207005308/en/
Media:
Jason Erkes, Cresco Labs
Chief Communications Officer
press@crescolabs.com
Investor Relations:
investors@crescolabs.com
For general Cresco Labs inquiries:
312-929-0993
info@crescolabs.com
Source: Cresco Labs
Are we at the bottom yet? or will it be after tax loss selling?
This could bode well for legal cannabis.
CT Lab Confirms Marijuana Laced With Fentanyl is a New Public Safety Threat.
This could bode well for legal cannabis
https://www.nbcconnecticut.com/news/local/ct-lab-confirms-marijuana-laced-with-fentanyl-is-a-new-public-safety-threat/2658007/
My CPA tells me that the maximum deduction on stock sale losses is $3000 per year.
Followers
|
133
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
3066
|
Created
|
08/22/15
|
Type
|
Free
|
Moderators |
We're on a mission to normalize, professionalize, and revolutionize cannabis.
Cresco Labs is one of the largest vertically-integrated multi-state cannabis operators in the United States. Cresco is built to become the most important company in the cannabis industry by combining the most strategic geographic footprint with one of the leading distribution platforms in North America. Employing a consumer-packaged goods (“CPG”) approach to cannabis, Cresco’s house of brands is designed to meet the needs of all consumer segments and includes some of the most recognized and trusted national brands including Cresco, Remedi and Mindy’s, a line of edibles created by James Beard Award-winning chef Mindy Segal. Sunnyside*, Cresco’s national dispensary brand, is a wellness-focused retailer designed to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco has launched the industry’s first national comprehensive Social Equity and Educational Development (SEED) initiative designed to ensure that all members of society have the skills, knowledge and opportunity to work in and own businesses in the cannabis industry.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |